ENTITY
Pharmaessentia Corp

Pharmaessentia Corp (6446 TT)

124
Analysis
Health Care β€’ Taiwan
PharmaEssentia Corporation develops and distributes therapeutic products for treatment in human disease. The Company develops drugs to treat hepatitis, chronic myeloid leukemia (CML), essential thrombocythemia (ET), myeloid fibrosis (MF), polycythemia vera (PV), hepatitis and cancer.
more
bullishβ€’Quantitative Analysis
β€’26 Feb 2024 08:00

TWSE Foreign Holding Weekly (Feb 23rd): Mediatek, TSMC, Evergreen Marine, Unimicron Tech, Novatek

We analyzed TWSE foreign holding data for the past week and highlighted foreign holding changes in Mediatek, TSMC, Evergreen Marine, Unimicron...

Logo
454 Views
Share
bearishβ€’Quantitative Analysis
β€’05 Feb 2024 08:00

TWSE Foreign Holding Weekly (Feb 2nd): TSMC, Asia Vital, Quanta Computer, Unimicron Tech, Umc

We analyzed TWSE foreign holding data for the past week and highlighted foreign holding changes in TSMC, Asia Vital, Quanta Computer, Unimicron...

Logo
596 Views
Share
bullishβ€’Quantitative Analysis
β€’28 Jan 2024 10:00

TWSE Foreign Holding Weekly (Jan 26th): TSMC, Alchip Tech, Pharmaessentia, Asmedia Tech, Umc

We analyzed TWSE foreign holding data for the past week and highlighted foreign holding changes in TSMC, Alchip Tech, Pharmaessentia, Asmedia Tech,...

Logo
564 Views
Share
x